LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Valent BioSciences Corporation (VBC) announced that the U.S. Environmental Protection Agency (EPA) has granted registration approval for VectoPrime™ Biological Larvicide for single-brood mosquito control. Through the power of BioFuse™ technology, VectoPrime is formulated with a specific ratio of Bacillus thuringiensis spp. israelensis Strain AM65-52 and (S)-methoprene developed through years of painstaking research. The result is a unique combination of efficacy, flexibility, and efficiency benefits to support U.S.-based mosquito abatement professionals.
The dual action of VectoPrime provides control from pre-hatch applications all the way through the 4th instar while delivering a host of related benefits. Asynchronous broods pose a significant challenge in the ongoing battle against mosquitos capable of transmitting harmful diseases such as West Nile virus, dengue fever, malaria, and encephalitis.
Help employers find you! Check out all the jobs and post your resume.
